Stockreport

Inovio Pharmaceuticals Inc (INO) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx
PDF Net Loss: Increased to $45.5 million or $0.87 per share, primarily due to a $22.5 million noncash loss on fair value adjustments related to warrant liabilities. Net L [Read more]